Concepedia
Author
Eva‐Maria Wagner‐Drouet
Also Known As
Eva-Maria Wagner-Drouet, Eva‐Maria Wagner‐Drouet
17
Publications
216
Citations
6
H-Index
0
Concepts
All Affiliations
×
All Concepts
5
192
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib, +22
Annals of Hematology
2020
65
Treosulfan compared with <scp>reduced‐intensity</scp> busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial
Dietrich W. Beelen, Matthias Stelljes, Péter Reményi, +30
American Journal of Hematology
2022
56
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, +93
The Lancet Haematology
2024
44
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
Eva M. Weissinger, Jochen Metzger, Michael Schleuning, +28
Leukemia
Thiotepa–fludarabine–treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial
Jürgen Finke, Claudia Schmoor, Matthias Stelljes, +11
Bone Marrow Transplantation
10
Page 1